title: Phase-II study of Navelbine in advanced breast cancer.
authors.affiliation: National Institute for Cancer Research, Genoa, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Canobbio
authors.forename: F
authors.initials: F
authors.lastname: Boccardo
authors.forename: G
authors.initials: G
authors.lastname: Pastorino
authors.forename: F
authors.initials: F
authors.lastname: Brema
authors.forename: C
authors.initials: C
authors.lastname: Martini
authors.forename: M
authors.initials: M
authors.lastname: Resasco
authors.forename: L
authors.initials: L
authors.lastname: Santi
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003248:Constipation / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008207:Lymphatic Metastasis; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
chemical_list: D000970:Antineoplastic Agents; D014747:Vinblastine; D000077235:Vinorelbine